Nymox Pharmaceutical Corp. sell StockNews.com
Start price
25.06.23
/
50%
€0.29
Target price
25.06.24
-
Performance (%)
-21.77%
End price
26.06.24
-
Summary
This prediction is currently being closed. The prediction for Nymox Pharmaceutical Corp. shows a convincing performance of -21.77%. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Nymox Pharmaceutical Corp. | - | - | - |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
Comments by StockNews_com for this prediction
In the thread Nymox Pharmaceutical Corp. diskutieren
Nymox Pharmaceutical Co. (NASDAQ: NYMX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for NYMX provided by MarketBeat
In the thread Trading Nymox Pharmaceutical Corp.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Stopped prediction by StockNews_com for Nymox Pharmaceutical Corp.
Nymox Pharmaceutical Corp.
Start price
Target price
Perf. (%)
€0.35
17.06.23
17.06.23
-
17.06.24
17.06.24
-33.91%
18.06.24
18.06.24
Nymox Pharmaceutical Corp.
Start price
Target price
Perf. (%)
€0.43
30.04.23
30.04.23
-
30.04.24
30.04.24
-47.00%
01.05.24
01.05.24
Nymox Pharmaceutical Corp.
Start price
Target price
Perf. (%)
€0.41
22.04.23
22.04.23
-
22.04.24
22.04.24
-43.90%
23.04.24
23.04.24
Nymox Pharmaceutical Corp.
Start price
Target price
Perf. (%)
€0.36
05.03.23
05.03.23
-
05.03.24
05.03.24
-35.75%
06.03.24
06.03.24
Nymox Pharmaceutical Corp.
Start price
Target price
Perf. (%)
€0.36
26.02.23
26.02.23
-
26.02.24
26.02.24
-35.75%
27.02.24
27.02.24